000 | 00985 a2200301 4500 | ||
---|---|---|---|
005 | 20250514173846.0 | ||
264 | 0 | _c20040305 | |
008 | 200403s 0 0 eng d | ||
022 | _a1473-3099 | ||
024 | 7 |
_a10.1016/S1473-3099(04)00909-0 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
245 | 0 | 0 |
_aBreaking the silence. _h[electronic resource] |
260 |
_bThe Lancet. Infectious diseases _cFeb 2004 |
||
300 |
_a63 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aCosts and Cost Analysis |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGovernment Programs _xeconomics |
650 | 0 | 4 |
_aHepatitis C _xcomplications |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLiver Cirrhosis _xetiology |
650 | 0 | 4 | _aPatient Rights |
650 | 0 | 4 | _aRefusal to Treat |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aUnited Kingdom |
773 | 0 |
_tThe Lancet. Infectious diseases _gvol. 4 _gno. 2 _gp. 63 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/S1473-3099(04)00909-0 _zAvailable from publisher's website |
999 |
_c14594855 _d14594855 |